Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia
Gillin, J.C.; Wyatt, R.J.
Psychopharmacology Bulletin 12(4): 12-13
1976
ISSN/ISBN: 0048-5764 PMID: 1067623 Document Number: 103824
Document emailed within 1 workday
Related Documents
Gillin, J.C.; Tinklenberg, J.; Stoff, D.M.; Stillman, R.; Shortlidge, J.S.; Wyatt, R.J. 1976: 5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals Biological Psychiatry 11(3): 355-358Strahilevitz, M.; Narasimhachari, N.; Fujimori, M.; Himwich, H.E. 1971: Blocking of 5-methoxy-n-dimethyltryptamine-induced EEG alerting in the rabbit by previous administration of antiserum to this compound Biological Psychiatry 3(3): 227-236
Wyatt, R.J.; Gillin, J.C.; Kaplan, J.; Stillman, R.; Mandel, L.; Ahn, H.S.; VandenHeuvel, W.J.; Walker, R.W. 1974: N,N-dimethyltryptamine--a possible relationship to schizophrenia? Advances in Biochemical Psychopharmacology 11: 299-313
Moron, J.; Rautureau, M.; Huel, C.; Pierré, A.; Berthier, L.K.; Atassi, G.; Bisagni, E. 1993: Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives Anti-Cancer Drug Design 8(6): 399-416
Eberle, D.O.; Hörmann, W.D. 1971: Fate of S-(2-methoxy-5-oxo-delta 2-1,3,4-thiadiazolin-4-yl)methyl)-O,O-dimethyl phosphorodithioate (Supracide) in field-grown agricultural crops and soil Journal - Association of Official Analytical Chemists 54(1): 150-159
LaBrosse, E.H.; Com-Nougué, C.; Zucker, J.M.; Comoy, E.; Bohuon, C.; Lemerle, J.; Schweisguth, O. 1980: Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors Cancer Research 40(6): 1995-2001
Meng, H.; Pierce, G.N. 1991: Involvement of sodium in the protective effect of 5-(N,N-dimethyl)-amiloride on ischemia-reperfusion injury in isolated rat ventricular wall Journal of Pharmacology and Experimental Therapeutics 256(3): 1094-1100
Philips, S.R.; Rozdilsky, B.; Boulton, A.A. 1978: Evidence for the presence of m-tyramine, p-tyramine, tryptamine, and phenylethylamine in the rat brain and several areas of the human brain Biological Psychiatry 13(1): 51-57
Vinnikova, A.N.; Utkina, N.S.; Danilov, L.L.; Torgov, V.I.; Druzhinina, T.N.; Veselovskiĭ, V.V. 2013: Synthesis and acceptor properties of 11-[(9'-anthracenyl)methoxy]undecyl phosphate and P1-{11-[(9'-anthracenyl)methoxy]undecyl}-P2-(alpha-D-galactopyranosyl) diphosphate in the enzymic reactions catalyzed by galactosylphosphotransferase and mannosyltransferase from Salmonella newport Bioorganicheskaia Khimiia 39(1): 99-104
Murav'ev, I.V.; Venikova, M.S.; Pleskovskaia, G.N.; Riazantseva, T.A.; Sigidin, I.A. 1991: Effect of dimethyl sulfoxide and dimethyl sulfone on a destructive process in the joints of mice with spontaneous arthritis Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 2: 37-39
Zawadowski, T.; Mazur, A.; Rump, S.; Borkowska, G. 1987: Synthesis of new amino ethers of 2,2-dimethyl- and 4,4-dimethyl-pyranocoumarins Acta Poloniae Pharmaceutica 44(3-4): 276-280
Itokawa, M.; Yoshikawa, T. 2003: Hypoglutamatergic hypothesis of schizophrenia: evidence from genetic studies Seishin Shinkeigaku Zasshi 105(11): 1349-1362
Bondy, B.; Ackenheil, M.; Birzle, W.; Elbers, R.; Fröhler, M. 1984: Catecholamines and their receptors in blood: evidence for alterations in schizophrenia Biological Psychiatry 19(10): 1377-1393
Thielemann, H. 1970: Studies of thin layer chromatographic separation of phenol, isomeric cresols, dimethyl-phenols and naphthols after reaction with 1-phenyl-2,3-dimethyl-4-aminopyrazolone-(5) or formation of azo dyes Die Pharmazie 25(7): 418-419
Lin, J.K.; Sung, S.S. 1975: Comparative studies on the carcinogenecities of N, N-dimethyl-4-aminoazobenzene and N'-acetyl-N'-methyl-4'-amino-N, N-dimethyl-4-aminoazobenzene in a normal diet Journal of the Formosan Medical Association 74(8): 534-540
Adler, L.E.; Pachtman, E.; Franks, R.D.; Pecevich, M.; Waldo, M.C.; Freedman, R. 1982: Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia Biological Psychiatry 17(6): 639-654
Klausner, J.D.; Sweeney, J.A.; Deck, M.D.; Haas, G.L.; Kelly, A.B. 1992: Clinical correlates of cerebral ventricular enlargement in schizophrenia. Further evidence for frontal lobe disease Journal of Nervous and Mental Disease 180(7): 407-412
Berneman, Z.N.; van Bockstaele, D.R.; Van den Bergh, M.; Van Roy, B.; Roete, L.; De Bock, R.; Korthout, M.; Peetermans, M.E.; Dumon, J. 1988: Karyotypic evidence for the leukemic involvement of the erythroblasts in erythroleukemia Leukemia 2(5): 296-299
Stoehr, R.; Krieg, R.C.; Knuechel, R.; Hofstaedter, F.; Pilarsky, C.; Zaak, D.; Schmitt, R.; Hartmann, A. 2002: No evidence for involvement of beta-catenin and APC in urothelial carcinomas International Journal of Oncology 20(5): 905-911
Schneble, N.; Wetzker, R.; Wollina, U. 2016: Lipedema lack of evidence for the involvement of tyrosine kinases Journal of Biological Regulators and Homeostatic Agents 30(1): 161-163